Concepedia

Carlo Marchetti

CM

Statistics

Publications

20

Citations

2.3K

H-Index

17

Active since

2012

Affiliations

University of Colorado Denver(Current)

Radboud University Nijmegen

Radboud University Medical Center

Virginia Commonwealth University

University of Colorado Anschutz Medical Campus

Carlo Marchetti is an author at University of Colorado Denver specializing in inflammation, nlrp3 inflammasome, and immunology.

ORCID

Publications per year

2012–2023

20

Publications

20

OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

Carlo Marchetti, Benjamin J. Swartzwelter, Fabia Gamboni et al. · Proceedings of the National Academy of Sciences · 2018 · 559 citations · Full text

, , +17

The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease

Niklas Lonnemann, Shirin Hosseini, Carlo Marchetti et al. · Proceedings of the National Academy of Sciences · 2020 · 293 citations · Full text

, , +17

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

Viola Klück, Tim Jansen, M. Janssen et al. · The Lancet Rheumatology · 2020 · 290 citations · Full text

, , +14

Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion

Isak W. Tengesdal, Dinoop Ravindran Menon, Douglas G. Osborne et al. · Proceedings of the National Academy of Sciences · 2021 · 193 citations · Full text

, , +17

NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis

Carlo Marchetti, Benjamin J. Swartzwelter, Marije I. Koenders et al. · Arthritis Research & Therapy · 2018 · 161 citations · Full text

, , +17

1–5 of 20